Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing
- National Inst. of Health (NIH), Bethesda, MD (United States). National Inst. of Allergy and Infectious Diseases. Lab. of Immunology. Molecular Biology Section
- National Inst. of Health (NIH), Bethesda, MD (United States). National Inst. of Biomedical Imaging and Bioengineering. Lab. of Cellular Imaging and Macromolecular Biophysics
- National Inst. of Health (NIH), Bethesda, MD (United States). National Inst. of Allergy and Infectious Diseases. Office of Cyber Infrastructure and Computational Biology. Bioinformatics and Computational Biosciences Branch
- Food and Drug Administration (FDA), Silver Spring, MD (United States). Center for Drug Evaluation and Research. Lab. of Immunology
- Univ. of Oklahoma Health Sciences Center, Oklahoma City, OK (United States). Dept. of Microbiology and Immunology
Peptide loading of major histocompatibility complex class I (MHC-I) molecules is central to antigen presentation, self-tolerance, and CD8+ T-cell activation. TAP binding protein, related (TAPBPR), a widely expressed tapasin homolog, is not part of the classical MHC-I peptide-loading complex (PLC). Using recombinant MHC-I molecules, we show that TAPBPR binds HLA-A*02:01 and several other MHC-I molecules that are either peptide-free or loaded with low-affinity peptides. Fluorescence polarization experiments establish that TAPBPR augments peptide binding by MHC-I. The TAPBPR/MHC-I interaction is reversed by specific peptides, related to their affinity. Mutational and small-angle X-ray scattering (SAXS) studies confirm the structural similarities of TAPBPR with tapasin. These results support a role of TAPBPR in stabilizing peptide-receptive conformation(s) of MHC-I, permitting peptide editing.
- Research Organization:
- National Institutes of Health (NIH), Bethesda, MD (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC); National Inst. of Health (NIH) (United States)
- Contributing Organization:
- Food and Drug Administration (FDA), Silver Spring, MD (United States); Univ. of Oklahoma Health Sciences Center, Oklahoma City, OK (United States)
- Grant/Contract Number:
- AC02-06CH11357; 9 P41 GM103622; AI0000394; EB000008; 1617
- OSTI ID:
- 1242290
- Journal Information:
- Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Issue 8; ISSN 0027-8424
- Publisher:
- National Academy of Sciences, Washington, DC (United States)Copyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Web of Science
Similar Records
Insights into MHC class I peptide loading from the structure of the Tapasin-ERp57 thiol oxidoreductase heterodimer
Differential tapasin dependence of MHC class I molecules correlates with conformational changes upon peptide dissociation: A molecular dynamics simulation study